Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Diffuse large B-cell lymphoma
ADR ID BADD_A01269
ADR Hierarchy
01      Blood and lymphatic system disorders
01.15      Lymphomas non-Hodgkin's B-cell
01.15.02      Diffuse large B-cell lymphomas
01.15.02.001      Diffuse large B-cell lymphoma
16      Neoplasms benign, malignant and unspecified (incl cysts and polyps)
16.28      Lymphomas non-Hodgkin's B-cell
16.28.02      Diffuse large B-cell lymphomas
16.28.02.001      Diffuse large B-cell lymphoma
Description Any of a group of malignant tumors of lymphoid tissue that differ from HODGKIN DISEASE, being more heterogeneous with respect to malignant cell lineage, clinical course, prognosis, and therapy. The only common feature among these tumors is the absence of giant REED-STERNBERG CELLS, a characteristic of Hodgkin's disease. [MeSH]
MedDRA Code 10012818
MeSH ID D008228
ADR Severity Grade (FAERS) Not Available
ADR Severity Grade (CTCAE) Not Available
Synonym
B-immunoblastic lymphoma (Kiel Classification) | B-large cell anaplastic Lymphoma (Kiel Classification) | Centroblastic (monomorphic, polymorphic, and multilobated subtypes) lymphoma (Kiel Classification) | Diffuse large B-cell lymphoma | Diffuse large B-cell lymphoma NOS | Diffuse large cell cleaved lymphoma (Working Formulation) | Diffuse large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation) | Diffuse mixed small and large cell lymphoma (Diffuse large B-cell lymphoma) (Working Formulation) | Large cell immunoblastic lymphoma (Diffuse large B-cell lymphoma) (Working Formulation) | Reticulosarcoma | Intravascular large B-cell lymphoma | Activated B-cell type diffuse large B-cell lymphoma | Germinal center B-cell type lymphoma | Double expressor lymphoma | Diffuse large B-cell lymphoma, unclassifiable, NOS | T-cell/histiocyte-rich large B-cell lymphoma | Germinal centre B-cell type lymphoma | KSHV/HHV8-positive diffuse large B-cell lymphoma | ALK-positive large B-cell lymphoma | Lymphoma, Non-Hodgkin | Lymphoma, Non Hodgkin | Lymphoma, Atypical Diffuse Small Lymphoid | Lymphoma, Non-Hodgkin's | Lymphoma, Non Hodgkin's | Lymphoma, Non-Hodgkin, Familial | Lymphoma, Non-Hodgkins | Lymphoma, Non Hodgkins | Non-Hodgkins Lymphoma | Small Cleaved-Cell Lymphoma, Diffuse | Small Cleaved Cell Lymphoma, Diffuse | Lymphoma, Nonhodgkins | Nonhodgkins Lymphoma | Lymphoma, Small Cleaved Cell, Diffuse | Lymphoma, Small Cleaved-Cell, Diffuse | Non-Hodgkin Lymphoma | Non Hodgkin Lymphoma | Non-Hodgkin's Lymphoma | Non Hodgkin's Lymphoma | Diffuse Small Cleaved-Cell Lymphoma | Diffuse Small Cleaved Cell Lymphoma | Lymphoma, Nonhodgkin's | Lymphoma, Nonhodgkin | Nonhodgkin's Lymphoma | Lymphoma, High-Grade | High-Grade Lymphoma | High-Grade Lymphomas | Lymphoma, High Grade | Lymphomas, High-Grade | Lymphoma, Intermediate-Grade | Intermediate-Grade Lymphoma | Intermediate-Grade Lymphomas | Lymphoma, Intermediate Grade | Lymphomas, Intermediate-Grade | Reticulum-Cell Sarcoma | Reticulum-Cell Sarcomas | Sarcomas, Reticulum-Cell | Reticulum Cell Sarcoma | Reticulosarcomas | Sarcoma, Reticulum-Cell | Sarcoma, Reticulum Cell | Lymphoma, Mixed-Cell | Lymphoma, Mixed Cell | Lymphoma, Mixed Lymphocytic-Histiocytic | Lymphocytic-Histiocytic Lymphoma, Mixed | Lymphocytic-Histiocytic Lymphomas, Mixed | Lymphoma, Mixed Lymphocytic Histiocytic | Lymphomas, Mixed Lymphocytic-Histiocytic | Mixed Lymphocytic-Histiocytic Lymphoma | Mixed Lymphocytic-Histiocytic Lymphomas | Mixed-Cell Lymphoma | Lymphomas, Mixed-Cell | Mixed Cell Lymphoma | Mixed-Cell Lymphomas | Lymphoma, Mixed | Lymphomas, Mixed | Mixed Lymphoma | Mixed Lymphomas | Lymphoma, Mixed-Cell, Diffuse | Diffuse Mixed-Cell Lymphoma | Diffuse Mixed Cell Lymphoma | Diffuse Mixed-Cell Lymphomas | Lymphoma, Diffuse Mixed-Cell | Lymphomas, Diffuse Mixed-Cell | Mixed-Cell Lymphomas, Diffuse | Lymphoma, Diffuse, Mixed Lymphocytic-Histiocytic | Mixed-Cell Lymphoma, Diffuse | Mixed Cell Lymphoma, Diffuse | Lymphoma, Mixed Small and Large Cell, Diffuse | Lymphoma, Small and Large Cleaved-Cell, Diffuse | Mixed Small and Large Cell Lymphoma, Diffuse | Diffuse Mixed Small and Large Cell Lymphoma | Lymphoma, Mixed Cell, Diffuse | Lymphoma, Small Noncleaved-Cell | Lymphoma, Small Noncleaved Cell | Small Non-Cleaved-Cell Lymphoma | Small Non Cleaved Cell Lymphoma | Lymphoma, Small Non-Cleaved-Cell | Lymphoma, Small Non Cleaved Cell | Lymphomas, Small Non-Cleaved-Cell | Non-Cleaved-Cell Lymphoma, Small | Non-Cleaved-Cell Lymphomas, Small | Small Non-Cleaved-Cell Lymphomas | Diffuse Undifferentiated Lymphoma | Diffuse Undifferentiated Lymphomas | Lymphoma, Diffuse Undifferentiated | Lymphomas, Diffuse Undifferentiated | Undifferentiated Lymphoma, Diffuse | Undifferentiated Lymphomas, Diffuse | Lymphoma, Undifferentiated, Diffuse | Small Noncleaved-Cell Lymphoma | Lymphomas, Small Noncleaved-Cell | Noncleaved-Cell Lymphoma, Small | Noncleaved-Cell Lymphomas, Small | Small Noncleaved Cell Lymphoma
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D00023Acetaminophen--
BADD_D00039Acyclovir0.000071%
BADD_D00194Azacitidine0.000168%
BADD_D00195Azathioprine0.001723%
BADD_D00230Bendamustine0.001063%
BADD_D00284Bortezomib0.000224%
BADD_D00318Busulfan--
BADD_D00429Chlorambucil0.000112%
BADD_D00511Clozapine--
BADD_D00551Cyclosporine0.000718%
BADD_D00556Cysteamine--
BADD_D00561Cytarabine hydrochloride--
BADD_D00589Dasatinib0.000224%
BADD_D00593Decitabine0.000224%
BADD_D00623Dexamethasone0.000218%
BADD_D00858Everolimus0.000612%
BADD_D00899Fingolimod hydrochloride--
BADD_D00914Fludarabine0.000280%
BADD_D01119Ibrutinib0.000895%
BADD_D01130Idelalisib0.000280%
BADD_D01136Imatinib0.000560%
BADD_D01252Leflunomide0.000428%
BADD_D01253Lenalidomide0.040893%
BADD_D01352Maraviroc--
BADD_D01392Mercaptopurine0.007807%
BADD_D01397Mesalamine0.000183%
BADD_D01418Methotrexate0.005003%
BADD_D01567Nilotinib0.000392%
BADD_D01831Prednisolone0.000210%
BADD_D01834Prednisone0.000027%
The 1th Page    1 2    Next   Last    Total 2 Pages